Rice Hall James & Associates’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-588,845
Closed -$5.52M 263
2023
Q2
$5.52M Buy
588,845
+34,661
+6% +$304K 0.31% 76
2023
Q1
$4.79M Buy
554,184
+121,343
+28% +$1.07M 0.27% 89
2022
Q4
$3.06M Sell
432,841
-15,692
-3% -$132K 0.18% 134
2022
Q3
$4.45M Buy
448,533
+43,786
+11% +$395K 0.26% 98
2022
Q2
$2.89M Buy
+404,747
New +$2.95M 0.14% 148

Other funds holding DCGO

Rice Hall James & Associates's DCGO Position: Q3 2023 in Review

Rice Hall James & Associates sold out of DocGo (DCGO) in Q3 2023, closing a stake of 588,845 shares — an estimated $5.52M sold.

Rice Hall James & Associates first reported a position in DCGO in Q2 2022 and held it in 5 quarters. The position peaked at $5.52M in Q2 2023. 143 funds tracked by Wall St. Rank hold DCGO as of Q3 2023.

  • Rice Hall James & Associates reported no remaining DocGo position as of Q3 2023 after selling out during the quarter.
  • Rice Hall James & Associates sold 588,845 DocGo shares in Q3 2023, an estimated $5.52M.
  • Rice Hall James & Associates first reported a position in DocGo in Q2 2022 and held it in 5 quarters.
  • Rice Hall James & Associates's DocGo position peaked at $5.52M in Q2 2023.
  • 143 funds tracked by Wall St. Rank held DocGo as of Q3 2023.

Based on Rice Hall James & Associates's 13F filing for Q3 2023, filed 2 Nov 2023.